ECOG-ACRIN has been instrumental in developing new standards of care for many types of cancer. The group's clinical trials often lead to FDA approval of new therapies and provide critical data that inform clinical practice guidelines. For example, ECOG-ACRIN studies have significantly impacted the use of immunotherapy and targeted therapies in cancer treatment.